← All organizations

Chroma Therapeutics

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 1, 2012

Defunct as of Jan 1, 2019

Timeline

2000s

Jun 1, 2000
Chroma Therapeutics— Founded

2010s

Jan 1, 2019
Chroma Therapeutics— Defunct

Drugs by trial phase (4 distinct, 10 trials)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

chr3996

Indications

Studied for

Recent trials (10)

NCT02759601CollaboratorPhase 1/Phase 2Dec 1, 2012
NCT01638442CollaboratorPhase 1Jun 1, 2012
NCT01180426Lead sponsorPhase 2Jun 1, 2010
NCT00780598Lead sponsorPhase 2Oct 1, 2009
NCT00820508Lead sponsorPhase 1Dec 1, 2008
NCT00697879Lead sponsorPhase 1Feb 1, 2008
NCT00522938Lead sponsorPhase 1/Phase 2Dec 1, 2007
NCT00737555Lead sponsorPhase 1Aug 1, 2006
NCT00689000Lead sponsorPhase 1/Phase 2May 1, 2006
NCT00692354Lead sponsorPhase 1Oct 1, 2004

Details

Founded: Oxton, GB Jun 1, 2000
Last known activity: Dec 1, 2012